Cargando…
Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439245/ https://www.ncbi.nlm.nih.gov/pubmed/32816197 http://dx.doi.org/10.1007/s11239-020-02253-x |
| _version_ | 1783572941426917376 |
|---|---|
| author | Abdel-Maboud, Mohamed Menshawy, Amr Elgebaly, Ahmed Bahbah, Eshak I. El Ashal, Gehad Negida, Ahmed |
| author_facet | Abdel-Maboud, Mohamed Menshawy, Amr Elgebaly, Ahmed Bahbah, Eshak I. El Ashal, Gehad Negida, Ahmed |
| author_sort | Abdel-Maboud, Mohamed |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7439245 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74392452020-08-20 Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis Abdel-Maboud, Mohamed Menshawy, Amr Elgebaly, Ahmed Bahbah, Eshak I. El Ashal, Gehad Negida, Ahmed J Thromb Thrombolysis Letter to the Editor Springer US 2020-08-20 2021 /pmc/articles/PMC7439245/ /pubmed/32816197 http://dx.doi.org/10.1007/s11239-020-02253-x Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Abdel-Maboud, Mohamed Menshawy, Amr Elgebaly, Ahmed Bahbah, Eshak I. El Ashal, Gehad Negida, Ahmed Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis |
| title | Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis |
| title_full | Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis |
| title_fullStr | Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis |
| title_full_unstemmed | Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis |
| title_short | Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis |
| title_sort | should we consider heparin prophylaxis in covid-19 patients? a systematic review and meta-analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439245/ https://www.ncbi.nlm.nih.gov/pubmed/32816197 http://dx.doi.org/10.1007/s11239-020-02253-x |
| work_keys_str_mv | AT abdelmaboudmohamed shouldweconsiderheparinprophylaxisincovid19patientsasystematicreviewandmetaanalysis AT menshawyamr shouldweconsiderheparinprophylaxisincovid19patientsasystematicreviewandmetaanalysis AT elgebalyahmed shouldweconsiderheparinprophylaxisincovid19patientsasystematicreviewandmetaanalysis AT bahbaheshaki shouldweconsiderheparinprophylaxisincovid19patientsasystematicreviewandmetaanalysis AT elashalgehad shouldweconsiderheparinprophylaxisincovid19patientsasystematicreviewandmetaanalysis AT negidaahmed shouldweconsiderheparinprophylaxisincovid19patientsasystematicreviewandmetaanalysis |